Literature DB >> 26266187

Grave Complication of Pharyngitis: Lemierre syndrome.

Suthar Pokhraj Prakashchandra1, Ankit Kumar B Patel2, Kimmyben Patel3, Raj Kumar P Doshi4, Narottam A Patel5.   

Abstract

Fusobacterium necrophorum is the causative agent in the pharyngitis. After invasion of the oropharyngeal mucosa by the organism leads to the development of the grave complications like superficial thrombophlebitis of internal jugular vein, septic emboli in the lung and coagulopathy. A 23-year-old male presented with chief complaints of sore throat, headache and high grade fever with past history of upper respiratory tract infection one month ago. On examination, he had high grade fever, tachycardia, hypotension and tender cervical lymph nodes. Oropharyngeal mucosa appeared ooedematous and congested. Leucocytosis with raised ESR was present. Blood culture positive for Fusobacterium necrophorum. Dilated right IJV with the hypoechoic thrombosis seen on Ultrasonography & Doppler. Patient was diagnosed as a case of Lemierre syndrome secondary to oropharyngeal infection was made. He was treated with intravenous imipenem and metronidazole, and then shifted to oral amoxicillin. After completion of full course of the therapy of 6 weeks, patient was improved clinically and all routine blood investigations were normalized. Blood culture was negative for Fusobacterium necrophorum. No evidence of thrombosis within the right internal jugular vein on Doppler.

Entities:  

Keywords:  Colour doppler; Complication of pharyngitis; Internal jugular vein

Year:  2015        PMID: 26266187      PMCID: PMC4525577          DOI: 10.7860/JCDR/2015/11917.6060

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

1.  Lemierre's Syndrome.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

Review 2.  Lemierre's syndrome: more than a historical curiosa.

Authors:  T Riordan; M Wilson
Journal:  Postgrad Med J       Date:  2004-06       Impact factor: 2.401

3.  Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 4.  The evolution of Lemierre syndrome: report of 2 cases and review of the literature.

Authors:  Julio A Chirinos; Daniel M Lichtstein; Javier Garcia; Leonardo J Tamariz
Journal:  Medicine (Baltimore)       Date:  2002-11       Impact factor: 1.889

5.  Frequency, microbial interactions, and antimicrobial susceptibility of Fusobacterium nucleatum and Fusobacterium necrophorum isolated from primary endodontic infections.

Authors:  Rogério C Jacinto; Francisco Montagner; Fernanda G C Signoretti; Geovania C Almeida; Brenda P F A Gomes
Journal:  J Endod       Date:  2008-10-19       Impact factor: 4.171

Review 6.  Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome.

Authors:  Terry Riordan
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

Review 7.  Lemierre's syndrome: A systematic review.

Authors:  Peter D Karkos; Sheetal Asrani; Christos D Karkos; Samuel C Leong; Evangelia G Theochari; Thalia D Alexopoulou; Assimakis D Assimakopoulos
Journal:  Laryngoscope       Date:  2009-08       Impact factor: 3.325

8.  Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey.

Authors:  L Hagelskjaer Kristensen; J Prag
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-11       Impact factor: 3.267

  8 in total
  2 in total

1.  Lemierre's Syndrome.

Authors:  Suad Marhoon Al Duwaiki; Aliya Sarhan Al Barwani; Sawsan Taif
Journal:  Oman Med J       Date:  2018-11

2.  Severe Sepsis Associated with Lemierre's Syndrome: A Rare but Life-Threatening Disease.

Authors:  Audrey Tawa; Raphaëlle Larmet; Yannick Malledant; Philippe Seguin
Journal:  Case Rep Crit Care       Date:  2016-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.